Dudediligence.

Royalty Pharma plc

RPRXNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$564.7MSep ’24$593.6MDec ’24$568.2MMar ’25$578.7MJun ’25$609.3MSep ’25$622.0MDec ’25$630.6MMar ’26$674.1MJun ’26
Net income, by quarter
$544.0MSep ’24$208.2MDec ’24$239.3MMar ’25$30.2MJun ’25$288.2MSep ’25$214.2MDec ’25$294.7MMar ’26$17.9MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$2.29B$2.24B$2.35B$2.26B$2.38B
Operating income$1.43B$307.1M$1.49B$1.29B$1.56B
Net income$619.7M$42.8M$1.13B$859.0M$770.9M
Operating cash flow$2.02B$2.14B$2.99B$2.77B$2.49B
Cash$1.54B$1.71B$477.0M$929.0M$618.7M
Debt$7.10B$7.12B$6.14B$7.61B$8.95B
Shares outstanding414.8M438.0M602.9M594.1M564.5M